CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

Attorneys say the FDA is unlikely to challenge the court’s decision, though Congress could still look to modernize lab test ...

CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which ...

GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump’s ...

The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

CFO Jamie Samath said in January that the stapler clearance would trigger the start of “broad commercial efforts” for the ...

Healthcare providers and medtech companies still face pressure to find ways to offset potential supply chain shocks despite ...

Microbot reported positive data on its single-use endovascular robot. Elsewhere, GE Healthcare named a new business leader, ...